Enterprise Value to EBITDA Multiple ratio Analysis of Longboard Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-8453.39
Period Ending - Dec-22
Very Poor EV to EBITDA
-7.13
Growth
-118487.93 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-9.86
EV to EBITDA Analysis of Longboard Pharmaceuticals Inc
| EV to EBITDA Ratio of LBPH drastically fell by -118487.93 % this year. |
Other EV to EBITDA Related Info of LBPH that may interest you.
Longboard Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LBPH | 18.87 | 17.9 | 5.42 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Longboard Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| EV to EBITDA | -8453.39 | -7.13 | -9.08 | -18.33 |
| Change | -118487.93 % | 21.46 % | 50.48 % |
FY Chart of Enterprise Value to EBITDA Multiple of Longboard Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)